Thymidylate synthase expression: An independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1378-1384

  Edler, David ^a,b   Hallström, Marja ^b   Johnston, Patrick G ^c   Magnusson, Inger ^a   Ragnhammar, Peter ^b   Blomgren, Henric ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CANCER; RECTUM RESECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034087575     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Johnston, P. G., Fisher, E. R., Rockette, H. E., Fisher, B., Wolmark, N., Drake, J. C., Chabner, B. A., and Allegra, C. J. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. Clin. Oncol., 12: 2640-2647, 1994.
2. Johnston, P. G., Lenz, H. J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichraan, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
3. Danenberg, P. V. Thymidylate synthase: a target enzyme in cancer chemotherapy. Biochim. Biophys. Acta, 473: 73-92, 1977.
4. Lenz, H. J., Danenberg, K. D., Leichman, C. G., Florentine, B., Johnston, P. G., Groshen, S., Zhou, L., Xiong, Y. P., Danenberg, P. V., and Leichman, L. P. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin. Cancer Res., 4: 1227-1234, 1998.
5. Lenz, H. J., Hayashi, K., Salonga, D., Danenberg, K. D., Danenberg, P. V., Metzger, R., Banerjee, D., Bertino, J. R., Groshen, S., Leichman, L. P., and Leichman, C. G. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin. Cancer. Res., 4. 1243-1250, 1998.
6. Yamachika, T., Nakanishi, H., Inada, K., Tsukamoto, T., Kato, T., Fukushima, M., Inoue, M., and Tatematsu, M. A new prognostic factor for colorectal carcinoma. Thymidylate synthase and its therapeutic significance. Cancer (Phila.), 82: 70-77, 1998.
7. 4PteGlu assays. Adv. Exp. Med. Biol., 244: 97-106, 1988.
8. Roberts, D. An isotopic assay for thymidylate synthetase. Biochemistry, 5; 3546-3548, 1966.
9. Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Volkenandt, M., Shea, L. C., Aigner, K., Gustavsson, P., Leichman, L., Frösing, R., Ray, M., Gibson, N. W., Spears, P. C., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase-gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
10. Johnston, P. G., Liang, C. M., Henry, S., Chabner, B. A., and Allegra, C. J. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res., 57: 6668-6676, 1991.
11. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54: 594-606, 1993.
12. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
13. Berge, T., Ekelund, G., Mellner, C., Phil, B., and Wenckert, A. Carcinoma of the colon and rectum in a defined population. Acta Chir. Scand., 438(suppl): 19-38, 1973.
14. Påhlman, L., and Glimelius, B. Local recurrences after surgical treatment for rectal carcinoma. Acta Chir. Scand., 150: 331-335, 1984.
15. Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. Cancer (Phila.), 66: 49-55, 1990.
16. Stockholm Rectal Cancer Study Group. Randomized study on preoperative radiation therapy in rectal carcinoma. Ann. Surg. Oncol., 3: 423-430, 1996.
17. Swedish Rectal Cancer Trial. Increased 5-year survival after pre-operative irradiation in rectal cancer (Abstract). Int. J. Colorect. Dis., 11: 128, 1996.
18. Swedish Rectal Cancer Trial. Local recurrence rate in a randomized multicenter trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur. J. Surg., 162: 397-402, 1996.
19. MacFarlane, J. K., Ryall, R. D. H., and Heald, R. J. Mesorectal excision for rectal cancer. Lancet, 341: 457-60, 1993.
20. Heald, R. J., and Ryall, R. D. H. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet, 28: 1479-82, 1986.
21. Dukes, C. E. The classification of cancer of the rectum. J. Pathol. Bacteriol., 35: 323-332, 1932.
22. Vojtesek, B., Bartek, J., Midgley, C. A., and Lane, D. P. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods, 151: 237-244, 1992.
23. Hsu, S. M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
24. Gehan, E. A. A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika, 52: 203-223, 1965.
25. Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., Gordon, P., Feldman, M., Cruz, A., Legauit-Poisson, S., Wexler, M., Lawrence, W., and Robidoux, A. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J. Natl. Cancer Inst., 80: 21-29, 1988.
26. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B, 34: 187-202, 1972.
27. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 55: 457-481, 1958.
28. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N. Engl. J. Med., 312: 1465-1472, 1985.
29. Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W. Kubista, T. P., Poon. M. A., Meyers, W. C., Maillard, J. A., Twito, D. I., Morton, R. F., Veeder, M. H., Witzig, T. E., Cha, S., and Vidyarthi, S. C. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med., 324: 709-715, 1991.
30. Pestalozzi, B. C., Peterson, H. F., Gelber, R. D., Goldhirch, A., Gusterson, B. A., Trihia, H., Lindtner, J., Cortes-Funes, H., Simmoncini, E., Byrne, M. J., Golouh, R., Ruderstam, C. M., Castiglione-Gertsch, M., Allegra, C. J., and Johnston, P. G. Prognostic importance of thymidylate synthase expression in early breast cancer. J. Clin. Oncol., 15: 1923-1931, 1997.
31. Findlay, M. P. N., Cunningham, D., Morgan. G., Clinton, S., Hardcastle, A., and Aherne, G. W. Lack of of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy. Br. J. Cancer, 75: 903-909, 1997.
32. Kitchens, M. E., and Berger, F. G. The relationship between mismatch repair defects and expression of thymidylate synthase in fluoropyrimidine-sensitive and resistant colon tumor cell lines. Proc. Am. Assoc. Cancer Res., 38: 614, 1997.
33. McLeod, H. L., and Murray, G. I. Tumour markers of prognosis in colorectal cancer. Br. J. Cancer, 79: 191-203, 1999.
34. Aschele, C., Debernardis, D., Casazza, S., Antonelli, G., Tunesi, G., Baldo, C., Lionetto, R., Maley, F., and Sobrero, A. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J. Clin. Oncol., 17: 1760-1770, 1999.
35. Leichman, C. G., Lenz., H., Leichman, L., Danenberg, K. D., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leukovorin. J. Clin. Oncol., 15: 3223-3229, 1997.
36. Davies, M. M., Johnston, P. G., Kaur, S., and Allen-Mersh, T. G. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine. Clin. Cancer Res., 5: 325-328, 1999.
37. Lenz, H. J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, L., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J., and Leichman, L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14: 176-182, 1995.
38. Kuniyasi, T., Nakamura, T., Tabuchi, Y., and Kuroda, Y. Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody. Cancer (Phila.), 83: 1300-1306, 1998.
39. Boku, N., Chin, K., Hosakawa, K., Ohtsu, A., Tajiri, H., Yoshida, S., Yamao, T., Kondo, H., Shirao, K., Shimada, Y., Saito, D., Hasebe, T., Mukai, K., Seki, S., Saito, H., and Johnston, P. G. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum. Clin. Cancer. Res., 4: 1469-1474, 1998.
40. Yeh, K. H., Shun, C. T., Chen, C. L., Lin, J. T., Lee, W. J., Lee, P. H., Chen, Y. C., and Cheng, A. L. High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy. Cancer (Phila.), 82: 1626-1631, 1998.
41. Alexander, H. R., Grem, J. L., Hamilton, J. M., Pass, H. I., Hong, M., Fraker, D. L., Steinberg, S. M., McAtee, N., Allegra, C. J., and Johnston, P. G. Thymidylate synthase protein expression is associated with response following neoadjuvant chemotherapy and resection for locally advanced gastric cancer. Cancer J. Sci. Am., 1: 49-54, 1995.
42. Johnston, P. G., Mick, R., Recant, W., Behan, K. A., Dolan, E., Ratain, M. J., Beckman, E., Weichselbaum, R. R., Allegra, C. J., and Vokes, E. E. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. J. Natl. Cancer Inst., 89: 308-313, 1997.
43. Lenz, H. J., Danenberg, K. D., Leichman, C. G., Hayashi, K., Metzger, R., Salonga, D., Kortes, V., Banerjee, D., Bertino, J. R., Groshen, S., Leichman, L. P., and Danenberg, P. V. p53 status and thymidylate synthase levels are predictors of chemotherapy efficacy in patients with advanced colorectal cancer. Proc. Am. Soc. Clin. Oncol., 15: 216, 1996.